Tag:

Parkinson's disease

Latest Headlines

Latest Headlines

U.K.'s MRC outlicenses Parkinson's discovery program to China's Yabao

The U.K. medical research institute MRC Technology--the tech transfer arm of the government's big Medical Research Council--has struck a deal to collaborate with China's Yabao Pharmaceutical on new Parkinson's drugs for the Asian market. In the deal, Yabao will dedicate part of its research effort to an unidentified kinase target for neurodegeneration.

Patients respond positively to Cynapsus film strip of apomorphine to combat Parkinson's

Cynapsus reported that 14 of the 16 Parkinson's disease patients responded positively in the Phase II trial of its reformulated thin-film strip version of the drug apomorphine, dubbed APL-130277, for the treatment of "off" episodes.

Cynapsus releases clinical trial data about its sublingual thin-film strip for Parkinson's

Cynapsus Therapeutics touted the results of its Phase 2 clinical trial of its sublingual thin-film-strip formulation of apomorphine for the management of OFF motor symptoms of Parkinson's disease.

Stanford using ultrasound to power wireless 'smart chip' implant

Stanford seems to have found a niche in tiny wireless implants. In the latest development, the university announced that it is developing methods of beaming ultrasound to power implanted "smart chips" for the treatment of conditions like Parkinson's disease.

Amicus drug improves Parkinson's symptoms in mice

Investigators at the University of California, Los Angeles, have found that a drug being studied for a rare genetic disorder called Gaucher disease also appears to slow the progression of Parkinson's disease in mice.

Civitas, NeuroDerm, EyeGate to pursue IPO dreams, combined $165M on the line

Israel's NeuroDerm filed for a stock offering on the basis of its subcutaneous formulation for treating Parkinson's; Civitas, the developer of an inhaled formulation for the disease, is expected to debut on the Nasdaq Sept. 24; and EyeGate Pharmaceuticals, which employs low-voltage electrical current to deliver eye medication, also just filed for an IPO.

Parkinson's biotech NeuroDerm joins the IPO queue with a $65M pitch

Israel's NeuroDerm is developing a wearable treatment solution for patients with Parkinson's disease, and the biotech is plotting a $65 million IPO to get its lead candidates across the finish line.

Parkinson's diagnostics expand as FDA clears wearable, researchers unveil smartphone app

Researchers are applying the full range of mobile technology to Parkinson's disease diagnostics. This week a pair of new technologies came to the fore, with a wearable device is cleared by FDA and a smartphone app unveiled at the British Science Festival.

Study finds blood-brain barrier opening can be controlled, enabling enhanced drug delivery

Columbia University scientists showed that it is possible to control the size of the blood-brain barrier opening by varying the pressure of an ultrasound beam, a discovery that could herald major breakthroughs in the treatment of neurological diseases.

Intel, Michael J. Fox Foundation start smartwatch study to track Parkinson's patients

A couple of major players are making moves to get wearable med tech a bit closer to reality. Intel has partnered with the Michael J. Fox Foundation to collect data via smartwatches on Parkinson's disease patients, tracking the progression of disease.